Streetbeat News

Price Targets

DNLI

Over the past 3 months, 4 Wall Street analysts have provided ratings for Denali Therapeutics (NASDAQ:DNLI), with 1 bullish and 3 somewhat bullish ratings. The average 12-month price target is $31.5, with a high of $35.00 and a low of $28.00, representing a significant decrease from the previous target of $85.00. This suggests a potential downside of 62.94% from the earlier price target.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:00 pm

SKY

Skyline Champion (NYSE:SKY) has received 5 analyst ratings in the last quarter, with 2 somewhat bullish and 3 indifferent, and no bearish or very bullish ratings. The average 12-month price target for SKY is $68.2, with a high of $78.00 and a low of $55.00. This target has increased by 4.92% over the past month. Analysts typically rate stocks each quarter and may adjust their predictions based on various research methods.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:00 pm

MFA

MFA Financial (NYSE:MFA) has received 4 analyst ratings in the last quarter, with 3 being somewhat bullish and 1 indifferent. The average price target is $12.25, representing an upside from the current price of $11.13. This target has decreased by 9.26% from the previous target of $13.50. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:00 pm

BONKUSD

DOGEUSD

PEPEUSD

Crypto analyst Kaleo warns that Pepe (CRYPTO: PEPE) is unlikely to reach all-time highs soon, advising against entering a long position until bullish momentum is observed. Kaleo's stance contrasts with analyst Michael Van de Poppe's bullish sentiment from last week, who suggested buying dips and projected a 30% surge for PEPE.

Portfolio Pulse from Mehab Qureshi

December 13, 2023 | 1:00 pm

FBIN

Fortune Brands (NYSE:FBIN) received 7 analyst ratings in the last quarter, with 3 bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target is $71.14, representing an 8.63% decrease from the previous target of $77.86. Analysts provide ratings based on research and forecasts, which can influence investor decisions.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 1:00 pm

COF

Morgan Stanley analyst Betsy Graseck upgraded Capital One Financial (COF) from Underweight to Equal-Weight and set a price target of $120.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:58 pm

VIAV

Rosenblatt analyst Mike Genovese has maintained a Buy rating on Viavi Solutions (NASDAQ:VIAV) and increased the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:51 pm

Rosenblatt analyst Catharine Trebnick has reaffirmed a Buy rating on Zscaler (NASDAQ:ZS) and increased the price target from $225 to $245.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:48 pm

CCCC

COHR

DHI

DRI

HCAT

JNJ

LULU

NOK

QTWO

TWLO

Wall Street analysts have updated their price targets and ratings for several companies. Nokia's price target was cut by Raymond James, while Q2 Holdings and C4 Therapeutics received price target boosts from Piper Sandler and Stifel, respectively. Lululemon's target was raised by Telsey Advisory Group, and Darden Restaurants' by Keybanc. Barclays increased D.R. Horton's target, JP Morgan raised Health Catalyst's, and Needham boosted Twilio's. Morgan Stanley lifted Coherent Corp.'s target but downgraded the stock, and Wells Fargo cut Johnson & Johnson's target and downgraded the stock.

Portfolio Pulse from Avi Kapoor

December 13, 2023 | 12:44 pm

AMBA

Rosenblatt analyst Kevin Cassidy has reiterated a Buy rating on Ambarella (NASDAQ:AMBA) and maintained the company's $85 price target.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 12:41 pm